Allotrope Medical develops the StimSite™ surgical device, which utilizes urine jet delivery technology to accurately identify and localize ureters during surgical procedures. This device enhances surgical safety and efficiency by preventing ureteral injuries, a common complication in pelvic surgeries.
Funding
$5.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NSRVTCTHFounders
Product
Problem
Ureteral injury is a common and serious complication in pelvic surgeries, often leading to significant patient morbidity and increased healthcare costs. Current methods for identifying and locating ureters during surgery can be unreliable, increasing the risk of accidental damage.
Solution
Allotrope Medical's StimSite™ device utilizes a urine jet delivery technology to provide surgeons with a more accurate and reliable method for ureteral identification and localization during surgical procedures. The StimSite™ system allows surgeons to precisely deliver a jet of urine, enabling real-time visualization of the ureters. This targeted delivery helps surgeons avoid accidental injury to the ureters, improving surgical outcomes and patient safety. By enhancing the precision of ureteral identification, StimSite™ contributes to increased surgical efficiency and reduced risk of complications.
Target Audience
The primary users are surgeons performing pelvic surgeries, including but not limited to hysterectomies, sacrocolpopexies, and colectomies.
Features
- Urine jet delivery technology for precise ureteral visualization
- Real-time ureteral identification during surgery
- Enhanced surgical safety through reduced risk of ureteral injury